Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Research Report 2024(Status and Outlook)
Report Overview
The global research and development of siRNA drugs is still in the development stage of the industry. There are about 300 projects after the global laboratory stage, and the overall development trend is good. Its therapeutic areas are mainly concentrated in tumor, neurology and ophthalmology. Since siRNA has a larger molecular weight and stronger charge than ASO, it is more difficult for siRNA to enter cells by itself, so siRNA drugs have higher requirements for carriers, which is why siRNA drugs are approved later than ASO drugs big reason.
This report provides a deep insight into the global siRNA Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global siRNA Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the siRNA Drug market in any manner.
Global siRNA Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Genzyme
Alnylam
Dicerna
Quark Pharmaceuticals
Arrowhead
Exicure
Miragen Therapeutics
Silence
Sylentis
Avidity Biosciences
Dicerna
BioNTech
Moderna Therapeutics
The WhiteOak Group, Inc.
Market Segmentation (by Type)
Givlaari
Patisiran
Givosiran
Market Segmentation (by Application)
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the siRNA Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The global research and development of siRNA drugs is still in the development stage of the industry. There are about 300 projects after the global laboratory stage, and the overall development trend is good. Its therapeutic areas are mainly concentrated in tumor, neurology and ophthalmology. Since siRNA has a larger molecular weight and stronger charge than ASO, it is more difficult for siRNA to enter cells by itself, so siRNA drugs have higher requirements for carriers, which is why siRNA drugs are approved later than ASO drugs big reason.
This report provides a deep insight into the global siRNA Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global siRNA Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the siRNA Drug market in any manner.
Global siRNA Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Genzyme
Alnylam
Dicerna
Quark Pharmaceuticals
Arrowhead
Exicure
Miragen Therapeutics
Silence
Sylentis
Avidity Biosciences
Dicerna
BioNTech
Moderna Therapeutics
The WhiteOak Group, Inc.
Market Segmentation (by Type)
Givlaari
Patisiran
Givosiran
Market Segmentation (by Application)
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the siRNA Drug Market
- Overview of the regional outlook of the siRNA Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the siRNA Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Antisense oligonucleotides (ASO) Drug and siRNA Drug
1.2 Key Market Segments
1.2.1 Antisense oligonucleotides (ASO) Drug and siRNA Drug Segment by Type
1.2.2 Antisense oligonucleotides (ASO) Drug and siRNA Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Manufacturers (2019-2024)
3.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Sites, Area Served, Product Type
3.6 Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Competitive Situation and Trends
3.6.1 Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antisense oligonucleotides (ASO) Drug and siRNA Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG INDUSTRY CHAIN ANALYSIS
4.1 Antisense oligonucleotides (ASO) Drug and siRNA Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Type (2019-2024)
6.3 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Market Share by Type (2019-2024)
6.4 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Price by Type (2019-2024)
7 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Sales by Application (2019-2024)
7.3 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Growth Rate by Application (2019-2024)
8 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG MARKET SEGMENTATION BY REGION
8.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region
8.1.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region
8.1.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Alnylam
9.1.1 Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.1.2 Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.1.3 Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.1.4 Alnylam Business Overview
9.1.5 Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug SWOT Analysis
9.1.6 Alnylam Recent Developments
9.2 Ionis
9.2.1 Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.2.2 Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.2.3 Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.2.4 Ionis Business Overview
9.2.5 Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug SWOT Analysis
9.2.6 Ionis Recent Developments
9.3 Biogen
9.3.1 Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.3.2 Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.3.3 Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.3.4 Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug SWOT Analysis
9.3.5 Biogen Business Overview
9.3.6 Biogen Recent Developments
9.4 Novartis
9.4.1 Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.4.2 Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.4.3 Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.4.4 Novartis Business Overview
9.4.5 Novartis Recent Developments
9.5 Sarepta Therapeutics
9.5.1 Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.5.2 Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.5.3 Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.5.4 Sarepta Therapeutics Business Overview
9.5.5 Sarepta Therapeutics Recent Developments
9.6 Therapeutics
9.6.1 Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.6.2 Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.6.3 Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.6.4 Therapeutics Business Overview
9.6.5 Therapeutics Recent Developments
9.7 Akcea
9.7.1 Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.7.2 Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.7.3 Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.7.4 Akcea Business Overview
9.7.5 Akcea Recent Developments
9.8 WAVElife
9.8.1 WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.8.2 WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.8.3 WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.8.4 WAVElife Business Overview
9.8.5 WAVElife Recent Developments
9.9 ProQR
9.9.1 ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.9.2 ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.9.3 ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.9.4 ProQR Business Overview
9.9.5 ProQR Recent Developments
9.10 Exicure
9.10.1 Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.10.2 Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.10.3 Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.10.4 Exicure Business Overview
9.10.5 Exicure Recent Developments
9.11 Secarna
9.11.1 Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.11.2 Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.11.3 Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.11.4 Secarna Business Overview
9.11.5 Secarna Recent Developments
9.12 AstraZeneca
9.12.1 AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.12.2 AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.12.3 AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.12.4 AstraZeneca Business Overview
9.12.5 AstraZeneca Recent Developments
9.13 The WhiteOak Group, Inc.
9.13.1 The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.13.2 The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.13.3 The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.13.4 The WhiteOak Group, Inc. Business Overview
9.13.5 The WhiteOak Group, Inc. Recent Developments
9.14 Dicerna
9.14.1 Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.14.2 Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.14.3 Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.14.4 Dicerna Business Overview
9.14.5 Dicerna Recent Developments
9.15 Silence
9.15.1 Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.15.2 Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.15.3 Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.15.4 Silence Business Overview
9.15.5 Silence Recent Developments
9.16 Arrowhead
9.16.1 Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.16.2 Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.16.3 Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.16.4 Arrowhead Business Overview
9.16.5 Arrowhead Recent Developments
9.17 Miragen Therapeutics
9.17.1 Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.17.2 Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.17.3 Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.17.4 Miragen Therapeutics Business Overview
9.17.5 Miragen Therapeutics Recent Developments
9.18 Genzyme
9.18.1 Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.18.2 Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.18.3 Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.18.4 Genzyme Business Overview
9.18.5 Genzyme Recent Developments
9.19 Quark Pharmaceuticals
9.19.1 Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.19.2 Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.19.3 Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.19.4 Quark Pharmaceuticals Business Overview
9.19.5 Quark Pharmaceuticals Recent Developments
9.20 Sylentis
9.20.1 Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.20.2 Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.20.3 Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.20.4 Sylentis Business Overview
9.20.5 Sylentis Recent Developments
9.21 Avidity Biosciences
9.21.1 Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.21.2 Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.21.3 Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.21.4 Avidity Biosciences Business Overview
9.21.5 Avidity Biosciences Recent Developments
10 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG MARKET FORECAST BY REGION
10.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast
10.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Country
10.2.3 Asia Pacific Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Region
10.2.4 South America Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antisense oligonucleotides (ASO) Drug and siRNA Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Antisense oligonucleotides (ASO) Drug and siRNA Drug by Type (2025-2030)
11.1.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Antisense oligonucleotides (ASO) Drug and siRNA Drug by Type (2025-2030)
11.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Forecast by Application (2025-2030)
11.2.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Antisense oligonucleotides (ASO) Drug and siRNA Drug
1.2 Key Market Segments
1.2.1 Antisense oligonucleotides (ASO) Drug and siRNA Drug Segment by Type
1.2.2 Antisense oligonucleotides (ASO) Drug and siRNA Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Manufacturers (2019-2024)
3.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Sites, Area Served, Product Type
3.6 Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Competitive Situation and Trends
3.6.1 Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antisense oligonucleotides (ASO) Drug and siRNA Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG INDUSTRY CHAIN ANALYSIS
4.1 Antisense oligonucleotides (ASO) Drug and siRNA Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Type (2019-2024)
6.3 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Market Share by Type (2019-2024)
6.4 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Price by Type (2019-2024)
7 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Sales by Application (2019-2024)
7.3 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Growth Rate by Application (2019-2024)
8 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG MARKET SEGMENTATION BY REGION
8.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region
8.1.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region
8.1.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Alnylam
9.1.1 Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.1.2 Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.1.3 Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.1.4 Alnylam Business Overview
9.1.5 Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug SWOT Analysis
9.1.6 Alnylam Recent Developments
9.2 Ionis
9.2.1 Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.2.2 Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.2.3 Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.2.4 Ionis Business Overview
9.2.5 Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug SWOT Analysis
9.2.6 Ionis Recent Developments
9.3 Biogen
9.3.1 Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.3.2 Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.3.3 Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.3.4 Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug SWOT Analysis
9.3.5 Biogen Business Overview
9.3.6 Biogen Recent Developments
9.4 Novartis
9.4.1 Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.4.2 Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.4.3 Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.4.4 Novartis Business Overview
9.4.5 Novartis Recent Developments
9.5 Sarepta Therapeutics
9.5.1 Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.5.2 Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.5.3 Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.5.4 Sarepta Therapeutics Business Overview
9.5.5 Sarepta Therapeutics Recent Developments
9.6 Therapeutics
9.6.1 Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.6.2 Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.6.3 Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.6.4 Therapeutics Business Overview
9.6.5 Therapeutics Recent Developments
9.7 Akcea
9.7.1 Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.7.2 Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.7.3 Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.7.4 Akcea Business Overview
9.7.5 Akcea Recent Developments
9.8 WAVElife
9.8.1 WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.8.2 WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.8.3 WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.8.4 WAVElife Business Overview
9.8.5 WAVElife Recent Developments
9.9 ProQR
9.9.1 ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.9.2 ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.9.3 ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.9.4 ProQR Business Overview
9.9.5 ProQR Recent Developments
9.10 Exicure
9.10.1 Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.10.2 Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.10.3 Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.10.4 Exicure Business Overview
9.10.5 Exicure Recent Developments
9.11 Secarna
9.11.1 Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.11.2 Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.11.3 Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.11.4 Secarna Business Overview
9.11.5 Secarna Recent Developments
9.12 AstraZeneca
9.12.1 AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.12.2 AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.12.3 AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.12.4 AstraZeneca Business Overview
9.12.5 AstraZeneca Recent Developments
9.13 The WhiteOak Group, Inc.
9.13.1 The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.13.2 The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.13.3 The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.13.4 The WhiteOak Group, Inc. Business Overview
9.13.5 The WhiteOak Group, Inc. Recent Developments
9.14 Dicerna
9.14.1 Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.14.2 Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.14.3 Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.14.4 Dicerna Business Overview
9.14.5 Dicerna Recent Developments
9.15 Silence
9.15.1 Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.15.2 Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.15.3 Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.15.4 Silence Business Overview
9.15.5 Silence Recent Developments
9.16 Arrowhead
9.16.1 Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.16.2 Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.16.3 Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.16.4 Arrowhead Business Overview
9.16.5 Arrowhead Recent Developments
9.17 Miragen Therapeutics
9.17.1 Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.17.2 Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.17.3 Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.17.4 Miragen Therapeutics Business Overview
9.17.5 Miragen Therapeutics Recent Developments
9.18 Genzyme
9.18.1 Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.18.2 Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.18.3 Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.18.4 Genzyme Business Overview
9.18.5 Genzyme Recent Developments
9.19 Quark Pharmaceuticals
9.19.1 Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.19.2 Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.19.3 Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.19.4 Quark Pharmaceuticals Business Overview
9.19.5 Quark Pharmaceuticals Recent Developments
9.20 Sylentis
9.20.1 Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.20.2 Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.20.3 Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.20.4 Sylentis Business Overview
9.20.5 Sylentis Recent Developments
9.21 Avidity Biosciences
9.21.1 Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
9.21.2 Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
9.21.3 Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Market Performance
9.21.4 Avidity Biosciences Business Overview
9.21.5 Avidity Biosciences Recent Developments
10 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG AND SIRNA DRUG MARKET FORECAST BY REGION
10.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast
10.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Country
10.2.3 Asia Pacific Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Region
10.2.4 South America Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antisense oligonucleotides (ASO) Drug and siRNA Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Antisense oligonucleotides (ASO) Drug and siRNA Drug by Type (2025-2030)
11.1.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Antisense oligonucleotides (ASO) Drug and siRNA Drug by Type (2025-2030)
11.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Forecast by Application (2025-2030)
11.2.1 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Comparison by Region (M USD)
Table 5. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense oligonucleotides (ASO) Drug and siRNA Drug as of 2022)
Table 10. Global Market Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Sites and Area Served
Table 12. Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Type
Table 13. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antisense oligonucleotides (ASO) Drug and siRNA Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Challenges
Table 22. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Type (Kilotons)
Table 23. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size by Type (M USD)
Table 24. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Type (2019-2024)
Table 26. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Share by Type (2019-2024)
Table 28. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons) by Application
Table 30. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size by Application
Table 31. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Application (2019-2024)
Table 33. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share by Application (2019-2024)
Table 35. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Region (2019-2024)
Table 38. North America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 44. Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 45. Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Alnylam Business Overview
Table 47. Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug SWOT Analysis
Table 48. Alnylam Recent Developments
Table 49. Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 50. Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 51. Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Ionis Business Overview
Table 53. Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug SWOT Analysis
Table 54. Ionis Recent Developments
Table 55. Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 56. Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 57. Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug SWOT Analysis
Table 59. Biogen Business Overview
Table 60. Biogen Recent Developments
Table 61. Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 62. Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 63. Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Novartis Business Overview
Table 65. Novartis Recent Developments
Table 66. Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 67. Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 68. Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Sarepta Therapeutics Business Overview
Table 70. Sarepta Therapeutics Recent Developments
Table 71. Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 72. Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 73. Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Therapeutics Business Overview
Table 75. Therapeutics Recent Developments
Table 76. Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 77. Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 78. Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Akcea Business Overview
Table 80. Akcea Recent Developments
Table 81. WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 82. WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 83. WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. WAVElife Business Overview
Table 85. WAVElife Recent Developments
Table 86. ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 87. ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 88. ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. ProQR Business Overview
Table 90. ProQR Recent Developments
Table 91. Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 92. Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 93. Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Exicure Business Overview
Table 95. Exicure Recent Developments
Table 96. Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 97. Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 98. Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Secarna Business Overview
Table 100. Secarna Recent Developments
Table 101. AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 102. AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 103. AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. AstraZeneca Business Overview
Table 105. AstraZeneca Recent Developments
Table 106. The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 107. The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 108. The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. The WhiteOak Group, Inc. Business Overview
Table 110. The WhiteOak Group, Inc. Recent Developments
Table 111. Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 112. Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 113. Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Dicerna Business Overview
Table 115. Dicerna Recent Developments
Table 116. Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 117. Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 118. Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Silence Business Overview
Table 120. Silence Recent Developments
Table 121. Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 122. Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 123. Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Arrowhead Business Overview
Table 125. Arrowhead Recent Developments
Table 126. Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 127. Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 128. Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Miragen Therapeutics Business Overview
Table 130. Miragen Therapeutics Recent Developments
Table 131. Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 132. Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 133. Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Genzyme Business Overview
Table 135. Genzyme Recent Developments
Table 136. Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 137. Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 138. Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Quark Pharmaceuticals Business Overview
Table 140. Quark Pharmaceuticals Recent Developments
Table 141. Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 142. Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 143. Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Sylentis Business Overview
Table 145. Sylentis Recent Developments
Table 146. Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 147. Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 148. Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 149. Avidity Biosciences Business Overview
Table 150. Avidity Biosciences Recent Developments
Table 151. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 152. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 153. North America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 154. North America Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 155. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 156. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 157. Asia Pacific Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 158. Asia Pacific Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 159. South America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 160. South America Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 161. Middle East and Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 162. Middle East and Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 163. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 164. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 165. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 166. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 167. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Comparison by Region (M USD)
Table 5. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense oligonucleotides (ASO) Drug and siRNA Drug as of 2022)
Table 10. Global Market Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Sites and Area Served
Table 12. Manufacturers Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Type
Table 13. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antisense oligonucleotides (ASO) Drug and siRNA Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Challenges
Table 22. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Type (Kilotons)
Table 23. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size by Type (M USD)
Table 24. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Type (2019-2024)
Table 26. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Share by Type (2019-2024)
Table 28. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons) by Application
Table 30. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size by Application
Table 31. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Application (2019-2024)
Table 33. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share by Application (2019-2024)
Table 35. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Region (2019-2024)
Table 38. North America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 44. Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 45. Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Alnylam Business Overview
Table 47. Alnylam Antisense oligonucleotides (ASO) Drug and siRNA Drug SWOT Analysis
Table 48. Alnylam Recent Developments
Table 49. Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 50. Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 51. Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Ionis Business Overview
Table 53. Ionis Antisense oligonucleotides (ASO) Drug and siRNA Drug SWOT Analysis
Table 54. Ionis Recent Developments
Table 55. Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 56. Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 57. Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Biogen Antisense oligonucleotides (ASO) Drug and siRNA Drug SWOT Analysis
Table 59. Biogen Business Overview
Table 60. Biogen Recent Developments
Table 61. Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 62. Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 63. Novartis Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Novartis Business Overview
Table 65. Novartis Recent Developments
Table 66. Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 67. Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 68. Sarepta Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Sarepta Therapeutics Business Overview
Table 70. Sarepta Therapeutics Recent Developments
Table 71. Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 72. Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 73. Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Therapeutics Business Overview
Table 75. Therapeutics Recent Developments
Table 76. Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 77. Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 78. Akcea Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Akcea Business Overview
Table 80. Akcea Recent Developments
Table 81. WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 82. WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 83. WAVElife Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. WAVElife Business Overview
Table 85. WAVElife Recent Developments
Table 86. ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 87. ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 88. ProQR Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. ProQR Business Overview
Table 90. ProQR Recent Developments
Table 91. Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 92. Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 93. Exicure Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Exicure Business Overview
Table 95. Exicure Recent Developments
Table 96. Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 97. Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 98. Secarna Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Secarna Business Overview
Table 100. Secarna Recent Developments
Table 101. AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 102. AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 103. AstraZeneca Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. AstraZeneca Business Overview
Table 105. AstraZeneca Recent Developments
Table 106. The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 107. The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 108. The WhiteOak Group, Inc. Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. The WhiteOak Group, Inc. Business Overview
Table 110. The WhiteOak Group, Inc. Recent Developments
Table 111. Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 112. Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 113. Dicerna Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Dicerna Business Overview
Table 115. Dicerna Recent Developments
Table 116. Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 117. Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 118. Silence Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Silence Business Overview
Table 120. Silence Recent Developments
Table 121. Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 122. Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 123. Arrowhead Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Arrowhead Business Overview
Table 125. Arrowhead Recent Developments
Table 126. Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 127. Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 128. Miragen Therapeutics Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. Miragen Therapeutics Business Overview
Table 130. Miragen Therapeutics Recent Developments
Table 131. Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 132. Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 133. Genzyme Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Genzyme Business Overview
Table 135. Genzyme Recent Developments
Table 136. Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 137. Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 138. Quark Pharmaceuticals Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Quark Pharmaceuticals Business Overview
Table 140. Quark Pharmaceuticals Recent Developments
Table 141. Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 142. Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 143. Sylentis Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Sylentis Business Overview
Table 145. Sylentis Recent Developments
Table 146. Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Basic Information
Table 147. Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Product Overview
Table 148. Avidity Biosciences Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 149. Avidity Biosciences Business Overview
Table 150. Avidity Biosciences Recent Developments
Table 151. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 152. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 153. North America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 154. North America Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 155. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 156. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 157. Asia Pacific Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 158. Asia Pacific Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 159. South America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 160. South America Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 161. Middle East and Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 162. Middle East and Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 163. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 164. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 165. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 166. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 167. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Antisense oligonucleotides (ASO) Drug and siRNA Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size (M USD), 2019-2030
Figure 5. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size (M USD) (2019-2030)
Figure 6. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size by Country (M USD)
Figure 11. Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Share by Manufacturers in 2023
Figure 12. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Share by Manufacturers in 2023
Figure 13. Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share by Type
Figure 18. Sales Market Share of Antisense oligonucleotides (ASO) Drug and siRNA Drug by Type (2019-2024)
Figure 19. Sales Market Share of Antisense oligonucleotides (ASO) Drug and siRNA Drug by Type in 2023
Figure 20. Market Size Share of Antisense oligonucleotides (ASO) Drug and siRNA Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Antisense oligonucleotides (ASO) Drug and siRNA Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share by Application
Figure 24. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Application in 2023
Figure 26. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share by Application (2019-2024)
Figure 27. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share by Application in 2023
Figure 28. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Country in 2023
Figure 32. U.S. Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Country in 2023
Figure 37. Germany Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Region in 2023
Figure 44. China Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Country in 2023
Figure 51. Brazil Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Antisense oligonucleotides (ASO) Drug and siRNA Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size (M USD), 2019-2030
Figure 5. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size (M USD) (2019-2030)
Figure 6. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size by Country (M USD)
Figure 11. Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Share by Manufacturers in 2023
Figure 12. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue Share by Manufacturers in 2023
Figure 13. Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antisense oligonucleotides (ASO) Drug and siRNA Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antisense oligonucleotides (ASO) Drug and siRNA Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share by Type
Figure 18. Sales Market Share of Antisense oligonucleotides (ASO) Drug and siRNA Drug by Type (2019-2024)
Figure 19. Sales Market Share of Antisense oligonucleotides (ASO) Drug and siRNA Drug by Type in 2023
Figure 20. Market Size Share of Antisense oligonucleotides (ASO) Drug and siRNA Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Antisense oligonucleotides (ASO) Drug and siRNA Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share by Application
Figure 24. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Application in 2023
Figure 26. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share by Application (2019-2024)
Figure 27. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share by Application in 2023
Figure 28. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Country in 2023
Figure 32. U.S. Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Country in 2023
Figure 37. Germany Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Region in 2023
Figure 44. China Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Country in 2023
Figure 51. Brazil Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Antisense oligonucleotides (ASO) Drug and siRNA Drug Market Share Forecast by Application (2025-2030)
